Other News

Maxim Simplifies Development of Wrist-Based Heart-Rate and SpO2 Monitoring Applications

Complete reference design saves up to 6 months in development cycle for health-monitoring wearables SAN JOSE, Calif., Feb. 19, 2020 /PRNewswire/ — Blood-oxygen saturation (SpO2), an indicator of oxygen levels in capillary blood, provides a wealth of insights into a person’s well-being. Coupled with other vital signs, SpO2 offers clues into areas […]

ARCA biopharma Announces Fiscal Year 2019 Financial Results and Provides Corporate Update

U.S. FDA Special Protocol Assessment agreement for a single pivotal Phase 3 clinical trial (PRECISION-AF) of genetically-targeted Gencaro PRECISION-AF clinical trial initiation anticipated fourth quarter of 2020 Trial to evaluate Gencaro as a potential treatment for prevention of atrial fibrillation in a heart failure population for which there are no […]

BioSig Completes 100th Patient Case with PURE EP(TM) System

WESTPORT, Feb. 19, 2020 (GLOBE NEWSWIRE) — Commercialization and install plan ahead of schedule Installations at new centers are driving patient enrollments and clinical data collection BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal […]

Conavi Medical and Japan Lifeline Announce MHLW Approval of Novasight Hybrid Intravascular Imaging System for Japanese Market

TORONTO–(BUSINESS WIRE)–ConaviTM Medical Inc. and Japan Lifeline are pleased to announce that they have received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for the Novasight HybridTM intravascular imaging system. The Novasight Hybrid system is the world’s first clinical system capable of providing both intravascular ultrasound (IVUS) and […]

ProtoKinetix Announces Progress in the use of AAGP® in Cardiovascular Medicine

MARIETTA, Ohio–(BUSINESS WIRE)–ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX) announces the progress of screening PKX-001 for cardiometabolic disorders. “Using isolated cardiac cells, we demonstrated that PKX-001 exerts cardioprotective effects in cells that are exposed to stress induced by nutrient overload or cardiotoxic drugs. Specifically, PKX-001 minimized cardiac cell damage […]

Canon Medical Receives FDA Clearance for Aquilion ONE / PRISM Edition, Enabling Deep Learning Spectral Capabilities for Routine Use

Spectral CT with Advanced intelligent Clear-IQ Engine (AiCE) Empowers Physicians with Deep Intelligence to Enable Routine Confident Diagnoses TUSTIN, Calif.–(BUSINESS WIRE)–Canon Medical Systems USA, Inc. has received 510(k) clearance for the Aquilion ONE / PRISM Edition, enabling Deep Learning Spectral capabilities that allow for more routine spectral imaging. Designed for deep […]

Premier Inc. ProvideGx™ Program Partners with Pfizer Inc. to Provide Corvert® and Vincristine to Providers

CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier Inc. (NASDAQ: PINC), through its ProvideGx™ program, has partnered with Pfizer Inc. to supply Corvert® (ibutilide fumarate injection) and Vincristine Sulfate Injection, USP, to healthcare providers, to help stabilize the long-term supply of two vital medications for its members. Corvert is an anti-arrhythmic heart medication used to treat […]

Cerus Endovascular Receives CE Mark Approval for its Contour Neurovascular System™, Designed to Treat Intracranial Aneurysms

Commercial Sales Across European Union Expected to Begin in Second Quarter of 2020 FREMONT, Calif. and OXFORD, England, Feb. 18, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its lead product, the Contour Neurovascular System™, for the treatment of […]